February 13, 2026 01:30 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers | Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six
AstraZeneca
WIKIMEDIA COMMONS

WHO to hold meeting on AstraZeneca Vaccine safety on Tuesday

| @indiablooms | Mar 16, 2021, at 02:42 pm

Geneva/Sputnik: The World Health Organization's (WHO) global advisory committee on vaccine safety will hold a meeting on Tuesday on the safety of the AstraZeneca vaccine, WHO Director General Tedros Adhanom Ghebreyesus said.

"The WHO's advisory committee on vaccine safety has been reviewing the available data, is in close contact with the European Medicines Agency and will meet tomorrow," Tedros said at a briefing.

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has scheduled an extraordinary meeting for March 18, during which it intends to evaluate all recent incidents related to vaccinations with AstraZeneca, the regulator said.

"EMA’s safety committee (PRAC) will further review the information tomorrow (Tuesday) and has called an extraordinary meeting on Thursday 18 March to conclude on the information gathered and any further actions that may need to be taken," the statement says.

EMA also confirmed that during the investigation, the regulator proceeds from the position that the benefits of the AstraZeneca vaccine outweigh the risks associated with it.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.